Search

Displaying results 7871 - 7880 of 10000 in total
  1. Drug

    Equol

    go.drugbank.com/drugs/DB11674
    Investigational

    Equol has been used in trials studying the treatment of Breast Cancer.

    Categories: Estrogens, Non-Steroidal
  2. Drug

    alpha-Hydroxy glycineamide

    go.drugbank.com/drugs/DB06568
    Experimental

    It also has an effect on viral gp160 envelope protein. [A31692] … Alpha-hydroxy glycineamide (αHGA) is the active antiviral metabolite of tri-peptide glycyl-prolyl-glycine-amide (GPG-NH2). αHGA inhibits the replication of HIV-1 in vitro by interfering with the capsid

  3. Drug

    SN-38

    go.drugbank.com/drugs/DB05482
    Investigational

    7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer … SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others.

  4. Drug

    Fluocortolone

    go.drugbank.com/drugs/DB08971
    ApprovedWithdrawn

    Fluocortolone is a glucocorticoid with anti-inflammatory activity used topically for various skin disorders.

    Mixtures: SCHERIPROCT N CREAMCategories: Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
  5. Drug

    Brolamfetamine

    go.drugbank.com/drugs/DB01484
    ExperimentalIllicit

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  6. Drug

    Colchiceine

    go.drugbank.com/drugs/DB15534
    Approved

    Colchiceine is one of several metabolites of the anti-gout medication [colchicine].[A192714]

    Synonyms: O-Demethylcolchicine, 10-O-demethylcolchicine
  7. Drug

    Afimoxifene

    go.drugbank.com/drugs/DB04468
    Investigational

    This technology enables percutaneous delivery of drugs that cannot be delivered orally. It is being developed by Ascent Therapeutics. … Afimoxifene (4-Hydroxytamoxifen, trade name TamoGel) is a new estrogen inhibitor under investigation for a variety of estrogen-dependent conditions, including cyclic breast pain and gynecomastia.

  8. Drug

    Josamycin

    go.drugbank.com/drugs/DB01321
    Investigational

    The drug has antimicrobial activity against a wide spectrum of pathogens.

  9. Drug

    Tymazoline

    go.drugbank.com/drugs/DB08803
    Experimental

    Tymazoline is a nasal preparation.

  10. Drug

    St. John's Wort

    go.drugbank.com/drugs/DB01323
    ApprovedNutraceutical

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome